Falk Hoffmann1, Gerd Glaeske. 1. Center for Social Policy Research, University of Bremen, Germany. hoffmann@zes.uni-bremen.de
Abstract
PURPOSE: Stock et al. (Eur Respir J 25:47-53, 2005) recently estimated asthma prevalence in Germany using claims data on prescriptions and hospital diagnoses and found high prevalence peaks in infants. Our objective was to critically assess and discuss various aspects of identifying children with asthma using prescription data. METHODS: We replicated the selection procedure of Stock et al. using data on 290,919 children aged 0-17 years insured in the Gmünder ErsatzKasse (GEK) in 2005. Asthma prevalence was also estimated in a sample of 17,641 children aged 0-17 years participating in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) from 2003 to 2006. RESULTS: In children aged 0-4 years insured in the GEK, prevalences were found to range from 11.7 to 17.7% for boys and from 7.2 to 11.1% for girls when the criteria of Stock et al. were applied. A steady decline in prevalences was observed in older age groups. Asthma prevalence estimated in the KiGGS data showed a quite different distribution. In the age group 0-4 years, prevalences were found to range from 0 to 2.6% in boys and from 0 to 1.0% in girls; in children >4 years, prevalences were found to increase with increasing age. CONCLUSIONS: When additional validation studies were taken into account, asthma medications were found to be prescribed not only for asthma but also for other respiratory diseases. In addition, not all children with current asthma had prescriptions. We therefore conclude that asthma medications are therefore not a good proxy for the disease.
PURPOSE: Stock et al. (Eur Respir J 25:47-53, 2005) recently estimated asthma prevalence in Germany using claims data on prescriptions and hospital diagnoses and found high prevalence peaks in infants. Our objective was to critically assess and discuss various aspects of identifying children with asthma using prescription data. METHODS: We replicated the selection procedure of Stock et al. using data on 290,919 children aged 0-17 years insured in the Gmünder ErsatzKasse (GEK) in 2005. Asthma prevalence was also estimated in a sample of 17,641 children aged 0-17 years participating in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) from 2003 to 2006. RESULTS: In children aged 0-4 years insured in the GEK, prevalences were found to range from 11.7 to 17.7% for boys and from 7.2 to 11.1% for girls when the criteria of Stock et al. were applied. A steady decline in prevalences was observed in older age groups. Asthma prevalence estimated in the KiGGS data showed a quite different distribution. In the age group 0-4 years, prevalences were found to range from 0 to 2.6% in boys and from 0 to 1.0% in girls; in children >4 years, prevalences were found to increase with increasing age. CONCLUSIONS: When additional validation studies were taken into account, asthma medications were found to be prescribed not only for asthma but also for other respiratory diseases. In addition, not all children with current asthma had prescriptions. We therefore conclude that asthma medications are therefore not a good proxy for the disease.
Authors: C Beimfohr; W Maziak; E von Mutius; H W Hense; W Leupold; T Hirsch; U Keil; S K Weiland Journal: Pharmacoepidemiol Drug Saf Date: 2001 Jun-Jul Impact factor: 2.890
Authors: Stephanie A K Stock; Björn Stollenwerk; Marcus Redaelli; Daniele Civello; Karl W Lauterbach Journal: J Womens Health (Larchmt) Date: 2008-04 Impact factor: 2.681
Authors: L B Bacharier; A Boner; K-H Carlsen; P A Eigenmann; T Frischer; M Götz; P J Helms; J Hunt; A Liu; N Papadopoulos; T Platts-Mills; P Pohunek; F E R Simons; E Valovirta; U Wahn; J Wildhaber Journal: Allergy Date: 2008-01 Impact factor: 13.146
Authors: Hartmut Vogt; Lennart Bråbäck; Olof Zetterström; Katalin Zara; Karin Fälth-Magnusson; Lennart Nilsson Journal: PLoS One Date: 2013-06-21 Impact factor: 3.240